Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement
1 other identifier
interventional
50
1 country
2
Brief Summary
Efficacy and Safety of Acupuncture Treatment as an Adjunctive Therapy After Knee Replacement
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 31, 2018
CompletedFirst Posted
Study publicly available on registry
August 16, 2018
CompletedStudy Start
First participant enrolled
November 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2021
CompletedJuly 8, 2021
July 1, 2021
2.1 years
July 31, 2018
July 7, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline in Korean version of Western Ontario and McMaster Universities Arthritis Index
K-WOMAC is widely used in the evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items divided into 3 subscales
Screening, day 11, day 21
Secondary Outcomes (6)
Change from baseline in Numeric rating scale
Screening, baseline, day 5, 11, 21, 28, 84
Change from baseline in Physical Condition related with mobility at every visit
Screening, day 11, day 84
Change from baseline in Physical Condition related with endurance at every visit
Screening, day 11, day 84
Change from baseline in Timed Up and Go Test at every visit
Screening, day 11, day 84
Change from baseline in Alternative-Step Test at every visit
Screening, day 11, day 84
- +1 more secondary outcomes
Study Arms (2)
Acupuncture + Usual care
EXPERIMENTALAcupuncture with Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet
Usual care
ACTIVE COMPARATORCnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet
Interventions
patients after surgery receive usual care(Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet) as well as acupuncture treatment as an adjunctive therapy
patients after surgery receive usual care alone(Cnoxane Injection 40mg, Esomezol Capsule, Synerjet Semi Tablet and Ocoron Tablet)
Eligibility Criteria
You may qualify if:
- Subject has a diagnosis of osteoarthritis and listed for an unilateral total knee replacement.
- Subject has a normal cognitive function
- Subject is willing and able to give informed consent for participation in the study.
You may not qualify if:
- Those who have undergone total knee arthroplasty due to gout
- Those who have had total knee arthroplasty due to trauma
- Those who have had total knee arthroplasty due to autoimmune related diseases such as rheumatoid arthritis
- Those who are participating in other clinical trials
- Those who have a history of participating in other clinical trials within one month
- Those who are difficult to write a research consent form
- Those who are judged to be inappropriate for the clinical study by the researchers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Catholic Kwandong University International St. Mary'S Hospital
Incheon, 22711, South Korea
Catholic Kwandong University International St. Mary'S Hospita
Incheon, 22761, South Korea
Related Publications (1)
Park TY, Kim HJ, Lee JH, Sunwoo YY, Do KS, Han SN, Song YK, Chae DS. Efficacy and safety of acupuncture treatment as an adjunctive therapy after knee replacement: Single-center, pragmatic, randomized, assessor blinded, pilot study. Medicine (Baltimore). 2021 Mar 12;100(10):e24941. doi: 10.1097/MD.0000000000024941.
PMID: 33725856DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yun Kyung Song, PhD
Gachon university of Gil oriental hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- single blinded, outcome assessor blinded
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Sponsor-principle investigator
Study Record Dates
First Submitted
July 31, 2018
First Posted
August 16, 2018
Study Start
November 30, 2018
Primary Completion
December 30, 2020
Study Completion
May 30, 2021
Last Updated
July 8, 2021
Record last verified: 2021-07